An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Sotera Health Company (NASDAQ: SHC) to present at the 42nd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Michael B. Petras, Jr. will lead the presentation, along with other key executives, discussing the company's mission-critical sterilization solutions and lab testing services for the healthcare industry.
Positive
None.
Negative
None.
CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm Eastern. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President and Treasurer, will participate in meetings with investors during the conference.
A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be archived on the Company's website.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:
Jason Peterson Vice President & Treasurer, Sotera Health IR@soterahealth.com
What is the upcoming event Sotera Health Company is participating in?
Sotera Health Company (NASDAQ: SHC) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm Eastern.
Who will be leading the presentation at the conference?
Chairman and CEO Michael B. Petras, Jr. will lead the presentation, along with other key executives.
Where can investors access the live webcast of the presentation?
Investors can access the live webcast of the presentation via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health.
Will there be a replay of the webcast available?
Yes, a replay of the webcast will be archived on the Company's website.
sotera health company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the united states and internationally. its sterilization services include gamma and electron beam irradiation, and eo processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. the company also provides co-60 and gamma irradiators, which are principal components to the gamma sterilization process. its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. the company was formerly known as sotera health topco, inc. and changed its name to sotera health company in october 2020. sotera health company was incorporated i
